Dabur India reports BSE has given a 'no adverse observations' on the Scheme of Amalgamation with Sesa Care, subject to statutory and shareholder approvals.
AI Assistant
Dabur India Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.